Picture of CVS logo

CVSG CVS News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

REG - CVS Group plc - Grant of Options & PDMR Dealing

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211126:nRSZ7234Ta&default-theme=true

RNS Number : 7234T  CVS Group plc  26 November 2021

 

 

26 November 2021

CVS Group plc

("CVS", the "Company" and, together with its subsidiaries, the "Group")

 

Grant of Options under CVS Group plc SAYE Option Scheme & PDMR
Dealing

CVS Group plc (the "Company") announces that as part of its
2021/2022 Save As You Earn share scheme (the "SAYE Scheme"), which is
open to all employees of the Group, the Executive Directors named below have
elected to participate in the SAYE Scheme and have been granted SAYE
Scheme options as follows:

 

Richard Fairman                           310 SAYE
scheme options

Robin Alfonso                               291
SAYE scheme options

Ben Jacklin
  310 SAYE scheme options

 

Eligible employees were invited to subscribe for options over the Company's
ordinary shares of 0.2 pence each ("Ordinary
Shares") with an exercise price of 1,974 pence per share, representing a 20% discount to the average
closing middle market price for the three dealing
days prior to 1 November 2021, being the invitation date.

 

In response to accepted invitations, a total of 215,022 SAYE
Scheme options over Ordinary Shares were granted on 25 November 2021,
equating to 0.30% of the current issued ordinary share capital.  Subject to
the rules of the SAYE Scheme, these options will be capable of exercise from
the maturity date on 1 January 2025.

 

The notification below, made in accordance with the requirements of UK MAR,
provides further detail.

 

 Contacts:

 CVS Group plc                                                                  via MHP Communications
 Richard Fairman, CEO
 Jenny Farrer, Company Secretary

 Singer Capital Markets (Nominated Adviser & Broker)                            +44 20 7496 3000
 Aubrey Powell / Jen Boorer / Rachel Hayes

 MHP Communications (Financial PR)                                              +44 20 3128 8549
 Andrew Jaques / Rachel Mann / Charles Hirst

 

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Richard Fairman
 2   Reason for the notification
 a)  Position/status                                              Chief Executive Officer
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         CVS Group plc
 b)  LEI                                                          213800J41XDQ2NX48O05
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Options over Ordinary shares of 0.2 pence each

     Identification code

                                                                  GB00B2863827
 b)  Nature of the transaction                                    Grant of Options under the SAYE Scheme.
 c)  Price(s) and volume(s)                                       Price(s)                  Volume(s)
                                                                  Exercise price of 1,974p  310

 

 d)  Aggregated information

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      25 November 2021
 f)  Place of the transaction                                     Off market

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Off market

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Robin Alfonso
 2   Reason for the notification
 a)  Position/status                                              Chief Financial Officer
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         CVS Group plc
 b)  LEI                                                          213800J41XDQ2NX48O05
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Options over Ordinary shares of 0.2 pence each

     Identification code

                                                                  GB00B2863827
 b)  Nature of the transaction                                    Grant of Options under the SAYE Scheme.
 c)  Price(s) and volume(s)                                       Price(s)                  Volume(s)
                                                                  Exercise price of 1,974p  291

 

 d)  Aggregated information

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      25 November 2021
 f)  Place of the transaction                                     Off market

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Off market

 

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Ben Jacklin
 2   Reason for the notification
 a)  Position/status                                              Chief Operating Officer
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         CVS Group plc
 b)  LEI                                                          213800J41XDQ2NX48O05
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Options over Ordinary shares of 0.2 pence each

     Identification code

                                                                  GB00B2863827
 b)  Nature of the transaction                                    Grant of Options under the SAYE Scheme.
 c)  Price(s) and volume(s)                                       Price(s)                  Volume(s)
                                                                  Exercise price of 1,974p  310

 

 d)  Aggregated information

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      25 November 2021
 f)  Place of the transaction                                     Off market

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Off market

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHGIBDBDBDDGBL

Recent news on CVS

See all news